The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of the efficacy of abirateron acetate with dutasteride for castration-resistant prostate cancer.
 
Hideyasu Matsuyama
Honoraria - AstraZeneca; Bayer; Janssen; MSD; Sanofi
Consulting or Advisory Role - Janssen; Sanofi
Research Funding - Astellas Pharma (Inst); Baxter (Inst); Bayer (Inst); Janssen (Inst); Kyowa-kirin (Inst); MSD Oncology (Inst); Pfizer (Inst); Takeda (Inst)
 
Masaki Shiota
Honoraria - Astellas Pharma; Bayer Yakuhin; Janssen; Sanofi; Takeda
 
Kojiro Tashiro
No Relationships to Disclose
 
Hiromi Kanji
No Relationships to Disclose
 
Shizuyo Horiyama
No Relationships to Disclose
 
Masatoshi Eto
Consulting or Advisory Role - Bristol-Myers Squibb; Chugai Pharma; Eisai; Johnson & Johnson; Merck; MSD Oncology; Novartis; Olympus; Ono Pharmaceutical; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Chugai Pharma; Janssen Oncology; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Kissei Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Takeda (Inst)
 
Shin Egawa
No Relationships to Disclose
 
Jun Haginaka
No Relationships to Disclose
 
Ryo Inoue
No Relationships to Disclose